MART-1 targeted nano vaccine (Tel Aviv University)

N/A

Report date: 2025/01/26 15:53:54

Base Information

Drug NameMART-1 targeted nano vaccine (Tel Aviv University)
Drug Alias NameMART-1/Melan-A melanoma vaccine (Tel Aviv University)melanoma vaccine (Tel Aviv University)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMelanoma antigen recognized by T-cells 1 modulators
TargetsMelanoma antigen recognized by T-cells 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesTel Aviv University
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A